Insider Trading & Ownership of Alison L. Hannah
-
Location
-
Fort Myers, FL
-
Summary
-
The estimated net worth of Alison L. Hannah is at least $1,448,309 dollars as of 03 Jun 2025. Alison L. Hannah is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $1.2M. Alison L. Hannah is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $202.5K. Alison L. Hannah is the Chief Medical Officer of CytomX Therapeutics, Inc. and owns shares of CytomX Therapeutics, Inc. (CTMX) stock worth about $44K.
-
Signature
-
/s/ Ali Olivo, Attorney-in-Fact
Follow Filing Activity
Follow Alison L. Hannah and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- Alison L. Hannah has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,448,309.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: NEOGENOMICS INC ($1,201,755).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Alison L. Hannah
Insider Transactions Reported by Alison L. Hannah:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.